Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxidative stress pathways in hepatocytes encompass the cellular mechanisms by which liver cells manage excess reactive oxygen and nitrogen species, particularly under conditions such as metabolic overload, xenobiotic exposure, or viral infection[2]. Key molecular players include the cytochrome P450 family (notably CYP2E1), NADPH oxidases (NOX1, NOX4), antioxidant enzymes (superoxide dismutase, catalase, glutathione peroxidase), and transcription factors such as NRF2 and NF-κB[1][3]. The dysregulation of these pathways leads to cellular damage, inflammation, fibrosis, and promotes the progression of diseases such as hepatocellular carcinoma and chronic liver conditions[1][2][3]. Targeting components of these pathways, particularly NRF2 activation and NOX1 inhibition, is pursued therapeutically to reduce liver injury and disease progression[1][3].
Scavenging of ROS - Induction of cellular antioxidant enzymes (via NRF2 activation) - Inhibition of ROS-producing enzymes (e.g., NOX inhibition, CYP regulation) - Modulation of inflammatory pathways (NF-κB, NLRP3 inflammasome)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxidative stress pathways in hepatocytes.